SDGR

Handel nachbörslich: 18.23

Schrodinger Inc (SDGR)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt SDGR? Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Schrodinger Inc Stock (SDGR) Company Profile

Schrodinger Inc

Healthcare (1196)

503-299-1150

1540 BROADWAY, NEW YORK, NY

@schrodinger

Nächster Verdiensttermin

Neueste SEC-Einreichungen

SDGR's Discussions on Twitter

Vergleichen Sie SDGR mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SDGR	18.23	1.32B	188.48M	-143.14M	-158.83M	0.56
VEEV	213.68	34.73B	2.57B	615.26M	996.76M	3.32
SOLV	67.12	11.43B	8.25B	404.00M	1.52B	0.00
DOCS	52.21	9.58B	493.63M	160.55M	162.20M	0.55
HQY	102.40	8.82B	1.10B	105.67M	-197.98M	0.1475
TEM	54.06	8.51B	640.44M	-743.28M	-206.93M	0.00

Schrodinger Inc Stock (SDGR) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-12-05	Eingeleitet	KeyBanc Capital Markets	Overweight
2023-05-05	Fortgesetzt	Piper Sandler	Overweight
2022-12-19	Eingeleitet	Goldman	Neutral
2022-03-01	Eingeleitet	Citigroup	Buy
2021-11-19	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2021-11-19	Eingeleitet	Piper Sandler	Overweight
2021-11-11	Herabstufung	BofA Securities	Buy → Neutral
2021-10-13	Eingeleitet	Berenberg	Buy
2021-09-01	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2021-05-25	Eingeleitet	Craig Hallum	Buy
2020-11-23	Hochstufung	BofA Securities	Neutral → Buy
2020-10-12	Hochstufung	Jefferies	Hold → Buy
2020-03-02	Eingeleitet	BMO Capital Markets	Outperform
2020-03-02	Eingeleitet	Jefferies	Hold
2020-03-02	Eingeleitet	Morgan Stanley	Equal-Weight

Alle ansehen

Schrodinger Inc Aktie (SDGR) Neueste Nachrichten

Finanzdaten der Schrodinger Inc-Aktie (SDGR)

Schrodinger Inc (SDGR)

Schrodinger Inc Stock (SDGR) Company Profile

Vergleichen Sie SDGR mit anderen Aktien

Schrodinger Inc Stock (SDGR) Upgrades & Downgrades

Schrodinger Inc Aktie (SDGR) Neueste Nachrichten

Schrödinger Broadens and Accelerates Predictive Toxicology Initiative - BioSpace

Schrödinger Secures $9.5M Gates Foundation Grant to Expand Drug Discovery Platform | SDGR Stock News - StockTitan

Sumitomo Mitsui Trust Group Inc. Increases Stake in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat

Leerink Partnrs Decreases Earnings Estimates for Schrödinger - MarketBeat

(SDGR) Technical Data - Stock Traders Daily

Schrodinger (SDGR): Stock Experiences 5% Decline Amid Market Flu - GuruFocus.com

Pier 88 Investment Partners LLC Buys 35,120 Shares of Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat

Schrödinger Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Midtown-based drug company inks $150M deal with Novartis - Crain's New York Business

Rubric Capital Management LP Increases Stake in Schrodinger Inc - GuruFocus.com

Schrödinger, Inc. Provides Earnings Guidance for the Fiscal Year Ending December 31, 2024 - Marketscreener.com

Schrodinger shares target increased, outperform rating on Novartis deal - Investing.com

Flare and Schrödinger join multibillion-dollar collaborations - BioWorld Online

Schrödinger announces collaboration with Novartis - The Pharma Letter

Schrödinger, Inc. (NASDAQ:SDGR) Q3 2024 Earnings Call Transcript - Insider Monkey

Schrodinger announces expanded license agreement with Novartis - Yahoo Finance

Baillie Gifford & Co. Has $36.75 Million Stock Position in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat

Market Participants Recognise Schrödinger, Inc.'s (NASDAQ:SDGR) Revenues Pushing Shares 26% Higher - Simply Wall St

Earnings call: Schrödinger reports dip in Q3 revenue, eyes Novartis deal - Investing.com UK

Schrodinger Inc (SDGR) Q3 2024 Earnings Call Highlights: Navigat - GuruFocus.com

Schrodinger Inc (SDGR) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges and ... By GuruFocus - Investing.com Canada

Schrodinger Inc (SDGR) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges and ... - Yahoo Finance

Schrödinger Reports Q3 2024 Earnings and New Novartis Collaboration - TipRanks

Schrodinger Inc (SDGR) Quarterly 10-Q Report - Quartzy

Schrödinger secures Novartis deal with potential $2.3 billion payout By Investing.com - Investing.com Australia

Schrödinger gains on Novartis deal despite Q3 miss - MSN

Blade Air Mobility Delivers Q3 Earnings Beat And Strong Margins As Restructuring Takes Flight - AOL

Schrodinger Inc (SDGR) Stock Price Up 13.36% on Nov 12 - GuruFocus.com

Schrödinger’s stock pops as it enters collaboration pact with Novartis worth up to $2.5 billion - MSN

Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details - Yahoo Finance

Schrödinger surges on Novartis collaboration agreement - ShareCast

Market news - Research the market

Schrödinger, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Schrodinger, Inc. (SDGR) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance

Schrödinger secures Novartis deal with potential $2.3 billion payout - Investing.com

Schrödinger enters collaboration pact with Novartis worth up to $2.5 billion - MarketWatch

Schrödinger Reports Third Quarter 2024 Financial Results - Business Wire

Schrödinger, Inc. Announces Multi-Target Collaboration and Expanded Software Licensing Agreement with Novartis - Marketscreener.com

Schrodinger Inc (SDGR) Q3 2024 Earnings Report Preview: What to Expect - GuruFocus.com

Schrödinger, Inc. (NASDAQ:SDGR) Shares Sold by ARK Investment Management LLC - MarketBeat

Schrödinger (SDGR) to Release Quarterly Earnings on Tuesday - MarketBeat

Schrödinger to Present at Jefferies London Healthcare Conference - BioSpace

(SDGR) Long Term Investment Analysis - Stock Traders Daily

How to Profit From an AI-Driven Biotech That Has Lost Half Its Value in 2024 - RealMoney

Schrödinger, Inc. (NASDAQ:SDGR) Shares Acquired by Stephens Investment Management Group LLC - MarketBeat

Schrödinger to Announce Third Quarter 2024 Financial Results on November 12 - Business Wire

Schrödinger, Inc. (NASDAQ:SDGR) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Trading (SDGR) With Integrated Risk Controls - Stock Traders Daily

Stanley Laman Group Ltd. Sells 33,556 Shares of Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat

Schrödinger Presents SGR-3515 Preclinical Data at 2024 EORTC-NCI-AACR Symposium - Business Wire

Schrödinger (NASDAQ:SDGR) Stock Price Up 6.2%Time to Buy? - MarketBeat

Finanzdaten der Schrodinger Inc-Aktie (SDGR)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie SDGR